{
  "docId": "019de070-7c63-7128-8a46-f79d73ca634e",
  "docSlug": "e7a5d9b34e946c6ef888782967ccb8f4",
  "documentTitle": "AbCellera | IPO Presentation Deck | 38 slides",
  "authorId": "abcellera",
  "authorName": "AbCellera",
  "documentKindSlug": "pitchdeck",
  "documentKindLabel": "Pitch deck",
  "sourceTypeSlug": "investment_bank",
  "sourceTypeLabel": "Investment bank",
  "presentationDate": "2020-12-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 4,
  "pageCount": 38,
  "prevPage": 3,
  "nextPage": 5,
  "slideType": "executive_summary",
  "function": "summarize",
  "density": "overcrowded",
  "nDataPoints": 5,
  "notes": "The slide uses a growth arrow graphic to anchor key company metrics and highlights.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de070-7c63-7128-8a46-f79d73ca634e/4",
  "deckHref": "/decks/019de070-7c63-7128-8a46-f79d73ca634e",
  "deckJsonHref": "/decks/019de070-7c63-7128-8a46-f79d73ca634e.json",
  "deckAnchorHref": "/decks/019de070-7c63-7128-8a46-f79d73ca634e#slide-4",
  "components": [
    {
      "bbox": {
        "h": 0.8,
        "w": 0.35,
        "x": 0.35,
        "y": 0.1
      },
      "kind": "chart",
      "text": "Growth arrow graphic",
      "attrs": null,
      "subkind": "line",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "aa7273e8-14ed-4f90-8ca5-0417b0363cee",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.08,
        "w": 0.25,
        "x": 0.68,
        "y": 0.6
      },
      "kind": "list",
      "text": "AbCellera-discovered COVID-19 antibody authorized for emergency use in the US & Canada",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "088d90d0-250c-4f88-aa6e-442c793b2483",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.15,
        "x": 0.75,
        "y": 0.46
      },
      "kind": "list",
      "text": "94 antibody discovery projects",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "16c844e9-b727-49eb-8d03-ed731cf12c3a",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.08,
        "w": 0.25,
        "x": 0.22,
        "y": 0.65
      },
      "kind": "list",
      "text": "Centralized business model for $140B antibody-based therapeutics market",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "2308c90f-1413-4a2e-9fda-74285fa0dcd4",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.25,
        "x": 0.11,
        "y": 0.815
      },
      "kind": "list",
      "text": "Full-stack AI-powered antibody discovery engine",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "54ae1c72-a3de-4493-800d-124f83f0d0ed",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.15,
        "x": 0.75,
        "y": 0.35
      },
      "kind": "list",
      "text": "174 employees; founded in 2012",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "90c9e6fc-5a9e-4d9b-8f3f-f14e0a3b085d",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.2,
        "x": 0.28,
        "y": 0.5
      },
      "kind": "list",
      "text": "Triple-digit CAGR, profitable, cashflow positive",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "933506b7-6f79-486f-8d98-9dc87656ffc2",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.3,
        "x": 0.65,
        "y": 0.8
      },
      "kind": "paragraph",
      "text": "BACKED BY LEADING HEALTHCARE & TECHNOLOGY INVESTORS TO SOLVE BIOLOGICS DISCOVERY & DEVELOPMENT INCLUDING: OrbiMed • DCVC Bio • Viking Global Investors • Peter Thiel • Founders Fund • Eli Lilly and Company • University of Minnesota • Presight Capital",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "67f92175-6fd2-4359-ad5c-5ec8fdab6e18",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.08,
        "w": 0.35,
        "x": 0.11,
        "y": 0.36
      },
      "kind": "paragraph",
      "text": "We believe the new frontier of technology lies at the interface of computation, engineering and biology.",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "6c7329e9-a873-42fe-a5da-550896af48e8",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.03,
        "w": 0.25,
        "x": 0.11,
        "y": 0.06
      },
      "kind": "title",
      "text": "INVESTOR HIGHLIGHTS",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "623eea91-ce20-45a0-a405-bd9e74326845",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.45,
        "x": 0.11,
        "y": 0.14
      },
      "kind": "title",
      "text": "TECHNOLOGY IS THE SUREST PATH TO A BETTER FUTURE.",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "cf7693ea-e94d-4974-b4ad-c74ed449162c",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [
    {
      "name": "Executive summary",
      "slug": "executive-summary",
      "agent": null,
      "layer": "slide",
      "matchId": "e696f33f-5a97-40e7-b223-9e1fc6c6feeb",
      "evidence": "The slide is titled 'TECHNOLOGY IS THE SUREST PATH TO A BETTER FUTURE' and provides a brief overview of the company's vision and highlights.",
      "confidence": 0.9
    }
  ],
  "frameworks": [],
  "arcBeats": [],
  "loops": [
    {
      "to": 38,
      "from": 4,
      "name": "Golden Circle",
      "slug": "11-golden-circle",
      "bestFor": "Visionary leadership, brand positioning, mission statements",
      "matchId": "0790a1a3-4790-4249-807c-1b7d69510973",
      "evidence": "The deck presents a clear 'why' for AbCellera's technology throughout",
      "position": 1,
      "objective": "Why is AbCellera's technology the right solution for antibody discovery?",
      "structure": "The Why (Belief) -> The How (Process) -> The What (Result)",
      "confidence": 0.7,
      "description": "Invert the typical pitch by starting with why you exist, rather than what you do"
    }
  ],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}